These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Should hyperlipidaemia in dialysis patients be treated? Wheeler DC Nephrol Dial Transplant; 1997 Jan; 12(1):19-21. PubMed ID: 9027766 [No Abstract] [Full Text] [Related]
5. Cardiovascular risk factors and blood pressure control in continuous ambulatory peritoneal dialysis. Lameire N Perit Dial Int; 1993; 13 Suppl 2():S394-5. PubMed ID: 8399620 [No Abstract] [Full Text] [Related]
6. Major and minor risk factors for cardiovascular disease in peritoneal dialysis. Prichard S Perit Dial Int; 2000; 20 Suppl 2():S154-9. PubMed ID: 10911662 [TBL] [Abstract][Full Text] [Related]
7. Cardiovascular problems in the choice of dialysis therapy for the elderly. Maiorca R Contrib Nephrol; 1994; 106():74-83. PubMed ID: 8174382 [No Abstract] [Full Text] [Related]
8. [Abnormality of lipid metabolism in patients on continuous ambulatory peritoneal dialysis (CAPD)]. Saito E; Matsuda N; Tanahashi Y; Makise J; Kanayama M Rinsho Byori; 1986 Sep; 34(9):1083-7. PubMed ID: 3795543 [No Abstract] [Full Text] [Related]
9. Hyperhomocysteinemia and oxidative stress during dialysis treatment. Chiarello PG; Vannucchi MT; Vannucchi H Ren Fail; 2003 Mar; 25(2):203-13. PubMed ID: 12739827 [TBL] [Abstract][Full Text] [Related]
10. Protective aspects for atherogenesis and lipid abnormalities in continuous ambulatory peritoneal dialysis patients. Nakagawa S; Ozawa K Perit Dial Int; 1993; 13 Suppl 2():S418-20. PubMed ID: 8399628 [No Abstract] [Full Text] [Related]
11. Prevalence of symptomatic arterial disease and risk factors for its development in patients on continuous ambulatory peritoneal dialysis. Webb AT; Brown EA Perit Dial Int; 1993; 13 Suppl 2():S406-8. PubMed ID: 8399624 [TBL] [Abstract][Full Text] [Related]